Tscan Therapeutics, Inc.
Clinical trials sponsored by Tscan Therapeutics, Inc., explained in plain language.
-
15-Year watch begins for patients who received experimental cancer cell therapy
Disease control Recruiting nowThis study will monitor 1,000 people for 15 years after they received an experimental T-cell therapy for blood cancers like leukemia. The goal is to track long-term safety and see how well the treatment continues to work over time. No new treatment is given in this study; researc…
Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scientists hunt clues in patient tissues to unlock autoimmune mysteries
Knowledge-focused Recruiting nowThis study aims to discover new targets for future autoimmune disease treatments by analyzing tissue and blood samples. Researchers will collect samples from 300 adults with conditions like Crohn's disease, multiple sclerosis, or ulcerative colitis during periods of active inflam…
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC